Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.

In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...

Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...

A new clinical trial found that pulsed-field catheter ablation using Boston Scientific's Farapulse system was more effective than medication in treating persistent atrial fibrillation. One year after ...

Electrophysiologists at UPMC Heart and Vascular Institute in Williamsport now offer pulsed field ablation (PFA), a new, ...

AVANT GUARD trial meets expectations despite pause for safety modifications ...

A major clinical trial has found Boston Scientific’s Farapulse pulsed-field ablation nearly doubles the success rate of treating persistent atrial fibrillation compared with medication. One year after ...

A minimally invasive heart procedure may be a better first-line treatment than medication for people living with advanced ...

There are both clinical and economic implications, as payers have been discouraging ablation in this population, one expert ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Tailored ablation guided by AI better prevented atrial ...

Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where ...

Real-world data presented at HRS 2026 add to the body of evidence supporting a shift away from short-duration Holter monitoring toward up to 14 ...